why choose us

First received: October 13, 2023

Clinical Trial: A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Patients With Previously Untreated Diffuse Large B-cell Lymphoma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Diffuse Large B-cell Lymphoma (DLBCL)

Study Type: INTERVENTIONAL


Official Title: A Phase 3, Open Label, Randomized Study Comparing the Efficacy and Safety of Odronextamab (REGN1979), an Anti-CD20 × Anti-CD3 Bispecific Antibody, in Combination With CHOP (O-CHOP) Versus Rituximab in

Brief Summary: This study is researching an experimental drug called odronextamab, referred to as study drug, when used in combination with chemotherapy.The study is focused on patients with diffuse large B-cell lymphoma (DLBCL) that have not been treated before (called "previously untreated"), have come back after treatment (called "relapsed"), or have not responded to treatment (called "refractory").This study will be made up of Part 1a, Part 1b, and Part 2.The aim of Part 1a and Part 1b of the…

Read more